Immatics N.V. (IMTX)
NASDAQ
$8.37+$0.0400 (+0.48%) on the dayAs of the close; data may be delayed.
IMTX price, last 12 months
Key stats
- Previous close
- $8.33
- Open
- $8.44
- Day range
- $8.25 – $8.50
- 52-week range
- $6.90 – $12.41
- Volume
- 277.7K
- Avg volume (20 days)
- 650.3K
- Market cap
- $1.3B
Performance
1W−2.9%
1M−11.2%
3M−12.1%
6M−14.3%
YTD−20.3%
1Y+14.2%
vs S&P 500, 1Y−2.6 pts
Technicals and fundamentals
About Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
- Listed on
- NASDAQ
- Market cap
- $1.3B